Enrollment in Australian Phase III Trial Also Has CommencedMALVERN, PA--Sep 10, 2007 -- Auxilium Pharmaceuticals, Inc. (NasdaqGM:AUXL ) today announced that the first patients have been dosed in the Company's second U.S. phase III pivotal trial and the... BiopharmaceuticalsAuxilium Pharmaceuticals, XIAFLEX, Dupuytren's contracture, U.S. CORD 1 (Source: HSMN NewsFeed)
Read More... [Source: MedWorm: Dupuytren's Contracture - Posted by FreeAutoBlogger]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment